文献速递糖尿病肥胖与代谢综合征

体重轨迹影响10种不同心血管代谢疾病的风险

Weight Trajectory Impacts Risk for 10 Distinct Cardiometabolic Diseases.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

研究利用1997至2020年范德堡大学医学中心成年患者的电子健康记录,采用标志点法和多变量Cox比例风险回归,比较体重稳定、增重、减重和体重循环四种轨迹与10种高发心血管代谢疾病的关系。结果显示,与体重稳定相比,体重循环与阻塞性睡眠呼吸暂停、代谢功能障碍相关脂肪性肝病和2型糖尿病风险约增加30%相关,与心力衰竭风险增加超过50%相关,且该关联独立于基线高BMI。

要点

  • 体重循环与阻塞性睡眠呼吸暂停风险增加约30%相关(HR 1.28;95%CI 1.15-1.42)。
  • 体重循环与代谢功能障碍相关脂肪性肝病风险增加约30%相关(HR 1.28;95%CI 1.08-1.51)。
  • 体重循环与2型糖尿病风险增加约23%相关(HR 1.23;95%CI 1.10-1.38)。

核心结论

  • 体重循环与心血管代谢疾病风险的关联独立于基线高BMI,且各体重轨迹组的基线BMI相似。
  • 研究结果支持在高BMI时促进体重稳定,或若减重能够维持则促进减重,以预防多种心血管代谢疾病的发生。

研究设计与样本

  • 使用1997至2020年范德堡大学医学中心所有接受治疗的成年患者去标识化电子健康记录数据,采用标志点法。
  • 开发多变量Cox比例风险回归模型,确定体重轨迹与10种高发心血管代谢疾病风险的关系。

主要发现

  • 与体重稳定相比,体重循环与阻塞性睡眠呼吸暂停风险增加近30%相关(HR 1.28;95%CI 1.15-1.42)。
  • 与体重稳定相比,体重循环与代谢功能障碍相关脂肪性肝病风险增加近30%相关(HR 1.28;95%CI 1.08-1.51)。
  • 与体重稳定相比,体重循环与2型糖尿病风险增加约23%相关(HR 1.23;95%CI 1.10-1.38)。
  • 与体重稳定相比,体重循环与心力衰竭风险增加超过50%相关(HR 1.54;95%CI 1.31-1.82),增重和减重也分别显示心力衰竭风险增加(HR 1.29;95%CI 1.08-1.55 和 HR 1.32;95%CI 1.10-1.58)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Repetitive bouts of weight loss and regain, termed weight cycling, may exaggerate the risk for cardiometabolic disease. We previously identified that weight cyclers were likely to have prescribed medications for hypertension, dyslipidemia, and diabetes-suggesting a high prevalence of cardiometabolic disease. OBJECTIVE: No prior study has compared relationships between longitudinal weight trajectory (weight stable, weight gainer, weight loser, or weight cycler) and commonly occurring specific cardiometabolic diseases among persons with similar high baseline body mass index (BMI). METHODS: Using de-identified electronic health record data from all adults treated at Vanderbilt University Medical Center between 1997 to 2020 and a landmark approach, we developed multivariate Cox proportional hazards regression models to determine relationships between weight trajectory and risk for 10 highly prevalent cardiometabolic diseases. RESULTS: Compared to weight stability, weight cycling associated with an almost 30% increased risk for obstructive sleep apnea [hazard ratio (HR) 1.28; 95% confidence interval (CI) 1.15-1.42], metabolic dysfunction-associated steatotic liver disease (HR 1.28; 95% CI 1.08-1.51), and type 2 diabetes (HR 1.23; 95% CI 1.10-1.38). Weight cycling also associated with a more than 50% increased risk for heart failure (HR 1.54; 95% CI 1.31-1.82), although both weight gain and weight loss also showed increased risk for heart failure (HR 1.29; 95% CI 1.08-1.55 and HR 1.32; 95% CI 1.10-1.58, respectively). CONCLUSION: The relationship between weight cycling and cardiometabolic disease risk was independent of having high baseline BMI, which was similar among weight trajectory groups. The present findings support promoting either weight stability at high BMI or weight loss if able to be maintained to prevent the incidence of a variety of cardiometabolic diseases.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Swartz AZ, Wood K, Farber-Eger E, et al. Weight Trajectory Impacts Risk for 10 Distinct Cardiometabolic Diseases. J Clin Endocrinol Metab. 2025. PMID: 40498904. doi:10.1210/clinem/dgaf348

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。